News

The University Psychiatric Services Bern (UPD) AG takes the concerns and worries of its employees seriously. It has therefore created an external reporting office in collaboration with BGPartner. All UPD employees have the opportunity to submit their observations, concerns and suggestions for improvement in connection with the safety of patients and employees externally and confidentially. The reports are anonymized and processed in such a way that no conclusion can be drawn as to the identity of the person making the report. However, BGPartner integrates the reports received into a reporting system so that UPD can draw the right conclusions from them and take appropriate measures.

Do you work for UPD? Then contact us now and let us contribute together to a constructive design.

It was great to attend the latest LAWorld EMEA Meeting in Oslo (Norway). The BGPartner delegation experienced and participated in interesting panel discussions, sharing of best practices and had many interesting conversations on various legal topics with LAWorld members from all over the world. The event proved once again that LAWorld is a unique and vibrant international legal network with strong ties amongst its highly professional members that go beyond any ordinary network.

Enjoy the video with some impressions and highlights from this event. Klick here for the Video.

BGPartner advised Araris Biotech Ltd in a CHF 24 million financing round, involving the two co-lead investors 4BIO Capital and Pureos Bioventures.

Araris Biotech Ltd, a company pioneering antibody-drug conjugate (ADC) linker technology, intends to use the proceeds to support advancement of lead ADCs in preclinical and into clinical development.

The round was co-led by 4BIO Capital and Pureos Bioventures, with participation from new investors, including Wille AG and the Institute for Follicular Lymphoma Innovation. The round also included participation from existing investors VI Partners, Schroders Capital, btov Partners and Redalpine.

“We’re thrilled to have support from this group of investors who recognize the potential of our linker technology in this exciting and growing ADC field and look forward to using these proceeds to support our efforts in advancing our ADC candidates toward the clinic” said Philipp Spycher, Ph.D., chief executive officer at Araris Biotech Ltd.

 The Araris Biotech Ltd press release can be found here.

BGPartner assisted Araris Biotech Ltd in the negotiations and advised on all Swiss legal matters regarding this financing round. The team was led by Oliver Gnehm (Partner) and further consisted of Thomas Gysin (Senior Associate).

More information about our negotiation expertise can be found here.

According to BILANZ Wirtschaftsmagazin and Le Temps BGPartner has been awarded four times in a row as top law firm in the area of "Private Equity and Venture Capital". Click here for the complete ranking.

BGPartner is pleased to welcome Tabea Hofer (Trainee) to the Berne team as of October 1, 2022. Further information on Tabea Hofer and our entire team can be found here.

Today we are launching our publication series on the topic of successful negotiations. In our first video Building the Foundation for Successful Negotiations we take a closer look on what negotiating actually is and how you can lay a solid foundation for making it successful. Click here and enjoy our Video.